Based on two important discoveries in the fight against hepatitis C, researchers at Stanford University say that an old drug may be effective against hepatitis C.
It was also discovered that an obsolete anti-itching, clemizole hydrochloride could obstruct the protein and reduce the replication of the virus.
Dr. Jeffrey Glenn, associate professor of gastroenterology and hepatology, has been quoted in the journal Nature, by stating, "We are excited about this and we are actively moving towards clinical trials." The research team studied more than 1200 candidates. According to Stephen Quake, PhD, professor of bioengineering, microfluidic technology has been used for the first time to discover a specific drug.
Co author Doron Gerber, with a PhD in bioengineering, when searching for specific drug has discovered 18 other drugs that substantially reduce the 'NS4B but focused on clemizole because, as noted, is believed to be safe for 'man.
Regarding the clemizole, Glenn said it could become an essential component of a new class of multidrug treatments for hepatitis C.
It was also discovered that an obsolete anti-itching, clemizole hydrochloride could obstruct the protein and reduce the replication of the virus.
Dr. Jeffrey Glenn, associate professor of gastroenterology and hepatology, has been quoted in the journal Nature, by stating, "We are excited about this and we are actively moving towards clinical trials." The research team studied more than 1200 candidates. According to Stephen Quake, PhD, professor of bioengineering, microfluidic technology has been used for the first time to discover a specific drug.
Co author Doron Gerber, with a PhD in bioengineering, when searching for specific drug has discovered 18 other drugs that substantially reduce the 'NS4B but focused on clemizole because, as noted, is believed to be safe for 'man.
Regarding the clemizole, Glenn said it could become an essential component of a new class of multidrug treatments for hepatitis C.
0 comments:
Post a Comment